Tenax Therapeutics (TENX) Cash from Investing Activities (2010 - 2023)
Tenax Therapeutics (TENX) reported Cash from Investing Activities of $157.0 for Q4 2023, down 96.08% on a YoY basis from $4000.0 in Q4 2022, and down 90.2% sequentially from $1602.0 in Q2 2023.
Tenax Therapeutics (TENX) Cash from Investing Activities (2010 - 2023) Analysis & Trends
Tenax Therapeutics (TENX) has 14 years of Cash from Investing Activities data on file, last reported at $157.0 in Q4 2023.
- For the quarter ending Q4 2023, Cash from Investing Activities fell 96.08% year-over-year to $157.0; the trailing twelve-month figure through Sep 2024 stood at $157.0 (down 97.71% YoY), and the FY2023 full-year result was $3000.0, up 229.14% from the prior year.
- Cash from Investing Activities slipped to $157.0 in Q4 2023, from $1602.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $511538.0 in Q3 2021 to a low of -$36964.0 in Q1 2021.
- A 5-year average of $27749.6 and a median of $157.0 in 2023 frame the typical range for Cash from Investing Activities.
- Peak annual rise in Cash from Investing Activities reached 18902.15% in 2021, while the deepest fall reached 483.95% in 2021.
- Tracing TENX's Cash from Investing Activities over 5 years: stood at -$16747.0 in 2019, then surged by 120.94% to $3506.0 in 2020, then tumbled by 148.43% to -$1698.0 in 2021, then jumped by 335.57% to $4000.0 in 2022, then slumped by 96.08% to $157.0 in 2023.
- Business Quant data shows TENX's Cash from Investing Activities at $157.0 in Q4 2023, $1602.0 in Q2 2023, and $1241.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -45.51 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -431.90 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -428.90 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 172.62 Mn |
| 10 | Tenax Therapeutics | 729.95 Mn | 729.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 157.00 |
| Dec 31, 2023 | 157.00 |
| Jun 30, 2023 | 1,602.00 |
| Jun 30, 2023 | 1,602.00 |
| Mar 31, 2023 | 1,241.00 |
| Mar 31, 2023 | 1,241.00 |
| Dec 31, 2022 | 4,000.00 |
| Dec 31, 2022 | 4,000.00 |
| Mar 31, 2022 | -6,323.00 |
| Mar 31, 2022 | -6,323.00 |
| Dec 31, 2021 | -1,698.00 |
| Dec 31, 2021 | -1,698.00 |
| Sep 30, 2021 | 511,538.00 |
| Sep 30, 2021 | 511,538.00 |
| Jun 30, 2021 | -20,267.00 |
| Jun 30, 2021 | -20,267.00 |
| Mar 31, 2021 | -36,964.00 |
| Mar 31, 2021 | -36,964.00 |
| Dec 31, 2020 | 3,506.00 |
| Dec 31, 2020 | 3,506.00 |